Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04798651
NA
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
Sponsor: University Hospital, Bordeaux
View on ClinicalTrials.gov
Summary
The study aims at identifying the type of B and CD4 T cell subsets with pathogenic properties in the different clinical forms of multiple sclerosis. This research might open new therapeutic approaches for the treatment of multiple sclerosis particularly progressive MS.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2021-09-30
Completion Date
2026-09
Last Updated
2026-02-03
Healthy Volunteers
No
Interventions
BIOLOGICAL
blood sample
28 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation
BIOLOGICAL
cerebro-spinal fluid
1 ml of cerebro-spinal fluid
Locations (1)
CHU de Bordeaux - service de neurologie
Bordeaux, France